Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
130064-09-4 | 6-Methyl-4-oxo-1,4-dihydroquinoline-2-carboxylic acid | AA00HRXO | MFCD09971510
1313367-62-2 | 2-[6-(benzyloxy)naphthalen-2-yl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | AA00HSCR | MFCD22493794
1330752-42-5 | 2-(2-Fluorophenoxy)ethanesulfonyl chloride | AA00HSNW | MFCD19675749
1335203-40-1 | 2-Amino-5-iodo-4-methoxy-benzoic acid | AA00HSVN | MFCD28968035
1341037-28-2 | 7-tert-Butyl 3-ethyl 8,9-dihydro-5h-imidazo[1,2-d][1,4]diazepine-3,7(6h)-dicarboxylate | AA00HT47 | MFCD27997387
1349717-75-4 | 4-(Hydrazinomethyl)pyridine trihydrochloride | AA00HTQQ | MFCD20233302
1354752-72-9 | (R)-Fmoc-3-benzyl-piperidine-3-carboxylic acid | AA00HU2X | MFCD26793614
136-90-3 | 4-Methoxy-3-methylaniline | AA00HUCR | MFCD07779234
1370600-52-4 | 3-Bromo-5-iodo-2-methyl benzoic acid methyl ester | AA00HUPW | MFCD20526667
1379915-20-4 | 3-Amino-3-(2-fluorophenyl)propan-1-ol hydrochloride | AA00HV4Q | MFCD06202379
